In Brief: AUA on cryosurgey
This article was originally published in The Gray Sheet
Executive Summary
AUA on cryosurgey: American Urological Association issues policy statement declaring cryosurgical treatment "one of the methods of management of adenocarcinoma of the prostate." AUA adds, however, that "the long-term curative efficacy of this treatment modality has not been established." The association also states that when cryosurgery is used, "appropriate disclosure of facts regarding all other treatment for prostate cancer should be made to the patient."...
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.